ARTICLE | Politics & Policy
Woodcock defends upcoming Avandia meeting
June 5, 2013 1:00 AM UTC
Janet Woodcock, director of FDA's Center for Drug Evaluation and Research, said this week's FDA meeting on Avandia rosiglitazone will enable "a transparent, public discussion" on the re-adjudicated re...